Complementation of deletion of the vaccinia virus E3L gene by the Escherichia coli RNase III gene

Virology

Volumn 227, Issue 1, 1997, Pages 77-87

  Shors, Teri ^a,b   Jacobs, Bertram L ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEASE;

ARTICLE; CONTROLLED STUDY; DELETION MUTANT; ESCHERICHIA COLI; GENE DELETION; GENETIC COMPLEMENTATION; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS;

ESCHERICHIA COLI; EUKARYOTA; VACCINIA; VACCINIA VIRUS;

EID: 0031555657     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8319     Document Type: Article

References (47)

1. Baier, L. J., Shors, T., Shors, S. T., and Jacobs, B. L. (1993). The mouse antiphosphotyrosine kinase, TIK, is indistinguishable from the double-stranded RNA-dependent, interferon-induced protein kinase, PKR. Nucleic Acids Res. 21, 4830-4835.
2. Bardwell, J. C. A., Regnier, P., Chen, S-M., Nakamura, Y., Grunberg-Manago, M., and Court, D. (1989). Autoregulation of RNase III operon by mRNA processing. EMBO J. 8, 3401-3407.
3. Beattie, E., Denzler, K. L., Tartaglia, J., Perkus, M. E., Paoletti, E., and Jacobs, B. L. (1995). Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69, 499-505.
4. Beattie, E., Paoletti, E., and Tartaglia, J. (1995). Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L-and E3L-mutant viruses. Virology 210(2), 254-263.
5. Burd, C. G., and Dreyfuss, G. (1994). Conserved structures and diversity of functions of RNA-binding proteins. Science 265, 615-621.
6. Chang, H-W., and Jacobs, B. L. (1993). Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. Virology 194, 537-547.
7. Chang, H.-W., Uribe, L. H., and Jacobs, B. L. (1995). Rescue of vaccinia virus deleted for the E3L gene by mutants of E3L. J. Virol. 69, 6605-6608.
8. Chang, H-W., Watson, J. C., and Jacobs, B. L. (1992). The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 89, 4825-4829.
9. Clemens, M. J., Hershey, J. W. B., Hovanessian, A. C., Jacobs, B. L., Katze, M. G., Kaufman, R. J., Lengyel, P., Samuel, C. E., Sen, G. C., and Williams, B. R. G. (1993). PKR: Proposed nomenclature for the RNA-dependent protein kinase induced by interferon. J. Interferon Res. 13, 241.
10. Court, D. (1993). RNA processing and degradation by RNase III. In "Control of Messenger RNA Stability." (J. G. Belasco and G. Brawerman, Eds.), pp. 71-116. Academic Press, San Diego.
11. Daly, C., and Reich, N. C. (1994). Receptor to nucleus signaling via tyrosine phosphorylation of the p91 transcription factor. Trends Endocrinol. Metab. 5, 159-164.
12. Dunn, J. J. (1976). RNase III cleavage of single-stranded RNA: Effect of ionic strength on the fidelity of cleavage. J. Mol. Biol. 251, 3807-3814.
13. Earl, P. and Moss, B. (1991). Expression of proteins in mammalian cells using vaccinia viral vectors. In "Current Protocols in Molecular Biology" (F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. A. Smith, J. G. Seidman, and K. Struh, Eds.), Supplement 15, Greene Publishing Associates and Wiley-Interscience, New York.
14. Falkner, F. G., and Moss, B. (1988). Escherichia coli gpt gene provides dominant selection for vaccinia open reading frame expression vectors. J. Virol. 62, 1849-1854.
15. Falkner, F. G., and Moss, B. (1990). Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64, 3108-3111.
16. Giantini, M., and Shatkin, A. J. (1989). Stimulation of chloramphenicol acetyltransferase mRNA translation by reovirus capsid polypeptide σ3 in cotransfected COS cells. J. Virol. 63, 2415-2421.
17. Ho, C. K., and Shuman, S. (1996). Mutational analysis of the vaccinia virus E3 protein defines amino acid residues involved in E3 binding to double-stranded RNA. J. Virol. 70, 2611-2614.
18. Hovanessian, A. G. (1989). The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J. Interferon Res. 9, 641-647.
19. Inada, T., Kawakami, K., Chen, S. M., Takiff, H. E., Court, D., and Nakamura, Y. (1989). Temperature sensitive lethal mutant of Era, a G-protein of Escherichia coli. J. Bacteriol. 171, 5017-5124.
20. Jacobs, B. L., and Langland, J. O. (1996). When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded RNA. Virology 219, 339-349.
21. Kaempfer, R., Israili, R., Rosen, H., Knoller, S., Zilberstein, A., Schmidt, A., and Revel, M. (1979). Reversal of the interferon-induced block of protein synthesis by purified preparations of eucaryotic initiation factor 2. Virology 99, 170-173.
22. Katze, M. G. (1992). The war against the interferon-induced dsRNA-activated protein kinase: can the viruses win? J. Interferon Res. 12, 241-248.
23. Kaufman, R. J., Davies, M. V., Pathak, V. K., and Hershey, J. W. B. (1989). The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol. Cell. Biol. 9, 946-958.
24. Kharrat, A., Macias, M. J., Gibson, T. J., Nilges, M., and Pastore, A. (1995). Structure of the dsRNA binding domain of E. coli RNase III. EMBO. J. 14(14), 3572-3584.
25. Kibler, K. V., Shors, T., Perkins, K. B., Zeman, C. C., Banaszak, M. P., Biesterfeldt, J., Langland, J. O., and Jacobs, B. L. (1996). Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol., submitted.
26. Kim, U., Wang, Y., Sanford, T., Zeng, Y., and Nishikura, K. (1994). Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc. Natl. Acad. Sci. USA 91, 11457-11461.
27. Kozak, M. (1987). An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125-8148.
28. Laemmli, U. K. (1970). Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227, 680-685.
29. Langland, J. O., Pettiford, S., Jang, B., and Jacobs, B. L. (1994). Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. J. Virol. 68, 3821-3829.
30. Mazzara, G. P., Destree, A., and Mahr, A. (1993). Generation and analysis of vaccinia virus recombinants. In "Methods in Enzymology" (R. Wu, Ed.), pp. 557-581. Academic Press, San Diego.
31. Nashimoto, H., and Uchida, H. (1985). DNA sequencing of the Escherichia coli ribonuclease III gene and its mutations. Mol. Gen. Genet. 201, 25-29.
32. Perkus, M. E., Kaufman, E. B., Taylor, J., Mercer, S., Smith, D., Vander-Hoeven, J., and Paoletti, E. (1993). Methodology of using vaccinia virus to express foreign genes in tissue culture. J. Tiss. Cult. Methods 15, 72-81.
33. Pines, O., Yoon, H.-J., and Inouye, M. (1988). Expression of double-stranded-RNA-specific RNase III of Escherichia coli is lethal to Saccharomyces cerevisiae. J. Bacteriol. 171, 588-592.
34. Robertson, H. D., Webster, R. E., and Zinder, N. D. (1968). Purification and properties of ribonuclease III from Escherichia coli. J. Biol. Chem. 243, 82-91.
35. Samuel, C. E. (1979). Mechanism of interferon action: Phosphorylation of protein synthesis initiation factor elF-2 in interferon-treated human cells by a ribosome-associated kinase possessing site-specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc. Natl. Acad. Sci. USA 76, 600-604.
36. Samuel, C. E. (1991). Antiviral actions of interferon: Interferon-regulated cellular proteins and their surprisingly selective antiviral properties. Virology 183, 1-11.
37. Samuel, C. E. (1993). The elF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268, 7603-7606.
38. Sheng, N., Zhang, J., Whitton, J. L., and McKee, T. (1993). A rapid and simple method for determining the DNA sequences of fragments inserted into vaccinia virus. Biotechniques 14, 781-784.
39. St. Johnston, D., Brown, N. H., Gall, J. G., and Jantsch, M. (1992). A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. USA 89, 10979-10983.
40. Staeheli, P. (1990). Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38, 147-199.
41. Watson, J., Chang, H. W., and Jacobs, B. L. (1991). Characterization of a vaccinia encoded double-stranded RNA binding protein that may be involved in inhibition of the double-stranded RNA-dependendent protein kinase. Virology 185, 206-216.
42. Wek, R. C. (1994). elF-2 kinases: Regulators of general and gene specific translation initiation. Trends Biochem. Sci. 19, 491-496.
43. Whitaker-Dowling, P., and Younger, J. S. (1983). Vaccinia rescue of VSV from interferon-induced resistance: Reversal of translation block and inhibition of protein kinase activity. Virology 131, 128-136.
44. Whitaker-Dowling, P., and Younger, J. S. (1986). Vaccinia-mediated rescue of encephalomyocarditis virus from the inhibitory effects of interferon. Virology 152, 50-57.
45. Younger, J., Thacore, H., and Kelly, M. (1972). Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell culture. J. Virol. 10, 171-180.
46. Yuwen, H., Cox, J. H., Yewdell, J. W., Bennink, J. R., and Moss, B. (1993). Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 195, 732-744.
47. Zhang, Y., and Moss, B. (1991). Inducer-dependent conditional-lethal mutant animal viruses. Proc. Natl. Acad. Sci. USA 88, 1511-1515.